Patches that lower testosterone by delivering oestradiol, a form of oestrogen, through the skin were just as effective as injections at preventing the cancer from spreading ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...

Credit: Getty Images The 2024 US Prostate Cancer Conference published 34 consensus recommendations addressing 5 main topic areas. Guidelines created by a multi-disciplinary panel of specialists focus ...

Carotuximab combined with Erleada showed a favorable safety profile in a phase 2 trial for metastatic castration-resistant prostate cancer. The trial, enrolling up to 100 participants, evaluates ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

Please provide your email address to receive an email when new articles are posted on . Nearly half of men with metastatic castration-resistant prostate cancer eligible for PARP inhibitors do not get ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programme Dr Kenrick Ng, Medical Oncology Consultant, St Bartholomew's Hospital, ...

SAN ANTONIO — A small pilot study delivered a big message about the use of testosterone in men with advanced or metastatic prostate cancer, according to a "Best Abstract" presented at the Sexual ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...